Home› Situations› LLY — Structural weakness emerging
Situation · 2026-04-24

LLY — Structural weakness emerging

Exceptional Profitability Meets Fragile Market Confidence

Updated 2026-04-14 · Ref: Drug Manufacturers - General
Key metrics — 2026-04-14
Peer score
68
Quality pct
100
Valuation pct
44
52w drawdown
-16.7%
21d vs sector
-12.2%
Peer group
Drug Manufacturers - General
Situation summary

Eli Lilly combines exceptional profitability (ROIC 37.76%) and rapid growth, yet market confidence remains fragile. Operational momentum is intact, but volatility (41.5%) and a low stability score keep the premium under pressure. The main stress lies in persistent risk perception, not fundamentals. A more anchored valuation would require market confidence to stabilize and volatility to ease.

Published by AssetNext · 2026-04-20

All companies with this signal today

View full list: Structural weakness emerging →

Related pages for LLY
Full peer analysis for Eli Lilly and Company →Similar companies to LLYLLY peersAll LLY comparisonsS&P 500 context
Signal history — last 30 days
Date Signal Peer score Drawdown 21d vs sector
2026-04-14 Structural weakness emerging 68 -16.7% -12.2%

See LLY's full peer analysis

Break down LLY's structural position across all peer dimensions with the interactive app.

Open LLY in AssetNext →